Simple Plex Discovery Control for CD28
R&D Systems, part of Bio-Techne | Catalog # 898743
Control for use with Discovery Human CD28 Simple Plex Assay Cartridge Kit
Key Product Details
Species
Human
Product Summary for Simple Plex Discovery Control for CD28
INTENDED USE AND DESCRIPTION: For use a quantitative control for the determination of human CD28 concentrations in biological fluids. Controls are supplied lyophilized. Please refer to the lot specific certificate of analysis and Simple Plex Lyophilized Quality Control product insert for additional information.”
Formulation, Preparation, and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
• Store lyophilized controls at 2-8 °C. Lyophilized controls are stable for up to 12 months from date of receipt.
• Reconstituted controls are stable for up to 6 months from date of preparation when stored at ≤ -70 °C. Storage at -20° C is not recommended.
• Individual frozen aliquots of low and high controls are designed as single-use entities. Thaw directly before use and discard any remaining volume.
• Reconstituted controls are stable for up to 6 months from date of preparation when stored at ≤ -70 °C. Storage at -20° C is not recommended.
• Individual frozen aliquots of low and high controls are designed as single-use entities. Thaw directly before use and discard any remaining volume.
Background: CD28
CD28 and CTLA-4, together with their ligands, B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD28 and CTLA-4 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Mouse CD28 is expressed constitutively on virtually 100% of mouse T cells and on developing thymocytes.
Alternate Names
CD28
Gene Symbol
CD28
Additional CD28 Products
Product Documents for Simple Plex Discovery Control for CD28
Product Specific Notices for Simple Plex Discovery Control for CD28
For research use only
Loading...
Loading...
Loading...